Statements (62)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:caused_by |
gptkb:virus
|
| gptkbp:characteristics |
gptkb:hemagglutinin
gptkb:neuraminidase |
| gptkbp:clinical_trial |
new antiviral agents
ongoing research |
| gptkbp:community_impact |
public health concern
|
| gptkbp:complications |
gptkb:healthcare_organization
bronchitis sinus infections worsening of chronic conditions |
| gptkbp:disease_resistance |
monitoring required
emergence of resistant strains |
| gptkbp:genetic_diversity |
antigenic drift
antigenic shift |
| gptkbp:global_presence |
hundreds of thousands of deaths annually
millions of infections annually |
| gptkbp:grooming_needs |
1 day before symptoms appear
contagious period up to 7 days after symptoms appear |
| gptkbp:healthcare |
gptkb:2009_H1_N1_pandemic
mask wearing quarantine social distancing |
| gptkbp:hosts |
gptkb:bird
gptkb:Person pigs |
| https://www.w3.org/2000/01/rdf-schema#label |
Influenza A
|
| gptkbp:is_monitored_by |
CDC monitoring
WHO monitoring |
| gptkbp:is_protected_by |
vaccination
|
| gptkbp:is_vulnerable_to |
varies by season
inactivated vaccine live attenuated vaccine depends on match to circulating strains |
| gptkbp:provides_information_on |
WHO recommendations
CDC recommendations |
| gptkbp:research |
vaccine development
viral evolution |
| gptkbp:risk_factor |
age
pregnancy chronic health conditions immunocompromised status |
| gptkbp:seasonal_activities |
winter months
|
| gptkbp:social_responsibility |
seasonal outbreaks
serological tests PCR test rapid influenza diagnostic tests viral culture |
| gptkbp:symptoms |
fatigue
cough fever sore throat muscle aches |
| gptkbp:transmission |
airborne droplets
|
| gptkbp:treatment |
supportive care
early intervention antiviral medications |
| gptkbp:type_of |
gptkb:H1_N1
gptkb:H3_N2 |
| gptkbp:bfsParent |
gptkb:H3_N2
|
| gptkbp:bfsLayer |
5
|